Hip Muscle Strength in FAI Versus Normal Controls

Femoro-acetabular Impingement Clinical Trial

Official title:

Muscle Strength in Femoroacetabular Impingement: A Comparative Study of Patients With FAI Versus Normal Controls

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02697097
• Other study ID #: AddenbrookesH
• Status: Not yet recruiting
• Phase: N/A
• First received: February 24, 2016
• Last updated: February 28, 2016
• Start date: April 2016
• Est. completion date: August 2017

Study information

• Verified date: February 2016
• Source: Cambridge University Hospitals NHS Foundation Trust
• Contact: Vikas Khanduja, MA, FRCS (Orth)
• Phone: 01223 257093
• Email: vk279[@]cam.ac.uk
• Is FDA regulated: No
• Health authority: United Kingdom: National Health Service
• Study type: Observational

Clinical Trial Summary

Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls.

To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular impingement (diagnosed clinically and with confirmed radiological features).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: August 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Males and Females.

• Aged 18-30.

• Control group - Normal range of movement and no evidence of femoro-acetabular impingement on clinical examination (negative impingement test, no symptoms).

• Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).

Exclusion Criteria:

• Patients under the age of 18.

• Patients over the age of 30.

• Control group - evidence of underlying pathology affecting the hip, abnormal range of motion, evidence of femoro-acetabular impingement on clinical examination.

• Previous surgery of the hip joints.

• Medical history of arthritis (including rheumatoid and reactive).

• Family history of femoro-acetabular impingement (control arm participants).

• Patients who are currently experiencing or have experienced hip pain in the previous 1 year (control arm).

• Other conditions (e.g. neurological, muscular dystrophy etc) which may affect hip muscle strength.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Femoracetabular Impingement
• Femoro-acetabular Impingement

Locations

Country	Name	City	State
United Kingdom	Addenbrooke's Hospital	Cambridge	Cambridgeshire

Sponsors (1)

Lead Sponsor	Collaborator
Cambridge University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscle Strength on Dynamometer		3 months	No
Secondary	Kinematics of the Hip - Range of Movement		3 months	No